Whitehawk Therapeutics (WHWK) Equity Ratio: 2018-2025
Historic Equity Ratio for Whitehawk Therapeutics (WHWK) over the last 8 years, with Sep 2025 value amounting to 0.94.
- Whitehawk Therapeutics' Equity Ratio rose 17.10% to 0.94 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.94, marking a year-over-year increase of 17.10%. This contributed to the annual value of 0.75 for FY2024, which is 6.06% down from last year.
- Whitehawk Therapeutics' Equity Ratio amounted to 0.94 in Q3 2025, which was down 1.11% from 0.95 recorded in Q2 2025.
- Whitehawk Therapeutics' Equity Ratio's 5-year high stood at 0.95 during Q2 2025, with a 5-year trough of 0.75 in Q4 2024.
- Over the past 3 years, Whitehawk Therapeutics' median Equity Ratio value was 0.85 (recorded in 2023), while the average stood at 0.85.
- Per our database at Business Quant, Whitehawk Therapeutics' Equity Ratio spiked by 230.80% in 2021 and then fell by 10.78% in 2024.
- Quarterly analysis of 5 years shows Whitehawk Therapeutics' Equity Ratio stood at 0.86 in 2021, then declined by 0.48% to 0.86 in 2022, then dropped by 7.59% to 0.79 in 2023, then declined by 6.06% to 0.75 in 2024, then increased by 17.10% to 0.94 in 2025.
- Its Equity Ratio was 0.94 in Q3 2025, compared to 0.95 in Q2 2025 and 0.95 in Q1 2025.